Remission Induction Versus Immediate Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Poor Responsive Acute Myeloid Leukemia (ASAP): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial-Reference-Cited by-同舟云学术

Remission Induction Versus Immediate Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Poor Responsive Acute Myeloid Leukemia (ASAP): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial

Published:2023 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Stelljes Matthias,Middeke Jan Moritz,Bug Gesine,Wagner-Drouet Eva-Maria,Müller Lutz P.,Schmid Christoph,Krause Stefan W.,Bethge Wolfgang,Jost Edgar,Platzbecker Uwe,Klein Stefan,Schubert Jörg,Niederland Judith,Kaufmann Martin,Schäfer-Eckart Kerstin,Schaich Markus,Baldauf Henning,Stölzel Friedrich,Petzold Cathleen,Röllig Christoph,Alakel Nael,Steffen Björn,Hauptrock Beate,Schliemann Christoph,Sockel Katja,Lang Fabian,Kriege Oliver,Schaffrath Judith,Reicherts Christian,Berdel Wolfgang E.,Serve Hubert,Ehninger Gerhard,Schmidt Alexander H.,Bornhäuser Martin,Mikesch Jan-Henrik,Schetelig Johannes

Publisher

Elsevier BV

Reference30 articles.

1. Reduced mortality after allogeneic hematopoietic-cell transplantation;T A Gooley;N Engl J Med,2010

2. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial;M Bornhauser;Lancet Oncol,2012

3. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes;B L Scott;J Clin Oncol,2017

4. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease;R Zeiser;N Engl J Med,2020

5. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia;R B Walter;J Clin Oncol,2011